"We look forward to working with the FDA and conti
Post# of 148171
(Total Views: 567)
Posted On: 01/13/2020 5:25:44 AM
"We look forward to working with the FDA and continuing to provide additional data that further supports leronlimab as a potential treatment option for patients.”
I am convinced that NP has received the green light from the FDA to apply for BTD. I see this as a rolling review, as 60 days pass, they will provide the FDA with data for other patients who will then justify getting BTD. I believe that the FDA is very interested in bringing this safe and effective drug to market as soon as possible, it is already very well tested, and the need is huge
I am convinced that NP has received the green light from the FDA to apply for BTD. I see this as a rolling review, as 60 days pass, they will provide the FDA with data for other patients who will then justify getting BTD. I believe that the FDA is very interested in bringing this safe and effective drug to market as soon as possible, it is already very well tested, and the need is huge
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼